From Mechanism to Management: The Link Between Inflammatory Bowel Disease and Cardiovascular Disease
Immunity, Inflammation and Disease · 2026-11 · 14 (11)
DOI: 10.1002/iid3.70570 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 10.11.2026. Verfasst von Farah Yasmin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Yale New Haven Health, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Inflammatory Bowel Diseases. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Inflammatory bowel diseases (IBDs) constituting the ulcerative colitis (UC) and Crohn's disease (CD) primarily affect the gastrointestinal tract and have been associated with the development of cardiovascular disease (CVDs). To strengthen this further, the focus of our narrative review is to highlight the clinical significance of understanding this association.
Methods
We conducted a narrative review to discuss the mechanisms of pathogenesis underlying the link between the management of inflammatory bowel disease and cardiovascular disease.
Discussion
The pathogenesis of the link likely involves dysregulated immune responses leading to overactivation of pro‐inflammatory cytokines, suggesting a shared inflammatory pathway. Both diseases share common risk factors such as obesity, diabetes, and gender. Genetic factors, including mutations in NOD2 and CDKN2A, also play a role in the overlap between IBDs and CVDs. Despite the recent developments, conventional cardiovascular risk assessment tools may not fully capture the potential elevated cardiovascular threat in IBD patients.
Conclusion
Thus, proactive investigation with advanced diagnostic tools such as coronary artery calcium (CAC) scoring is crucial in reducing cardiovascular morbidity and mortality in these patients. Nevertheless, future research is needed to further clarify disease activity and its correlations. Clinical Trials Registration NA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Yale New Haven Health, New Haven, Connecticut, USA.
- Department of Internal Medicine, Liaquat University of Medical & Health Sciences, Jamshoro, Pakistan.
- Department of Internal Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan.
- Department of Internal Medicine, Foundation University Medical College, Islamabad, Pakistan.
- Department of Internal Medicine, Bilawal Medical College, Jamshoro, Pakistan.
- Department of Internal Medicine, AdventHealth, Sebring, Florida, USA.
ORCID-Profile: Asad Ur Rab, Muhammad Saeed Qazi, Muhammad Sohaib Asghar, Mohammed Mahmmoud Fadelallah Eljack, Krutarth Pandya, M Chadi Alraies
Zitieren
APA
Yasmin, F., Ahmed, M., Bin Iftikhar, T., Rab, A. U., Qazi, M. S., Asghar, M. S., Eljack, M. M. F., Pandya, K., & Alraies, M. C. (2026). From Mechanism to Management: The Link Between Inflammatory Bowel Disease and Cardiovascular Disease. Immunity, Inflammation and Disease, 14(11). https://doi.org/10.1002/iid3.70570
Vancouver
Yasmin F, Ahmed M, Bin Iftikhar T, Rab AU, Qazi MS, Asghar MS, et al. From Mechanism to Management: The Link Between Inflammatory Bowel Disease and Cardiovascular Disease. Immunity, Inflammation and Disease. 2026;14(11). doi:10.1002/iid3.70570
BibTeX
@article{Yasmin2026,
author = {Yasmin, Farah and Ahmed, Mansoor and Bin Iftikhar, Taha and Rab, Asad Ur and Qazi, Muhammad Saeed and Asghar, Muhammad Sohaib and Eljack, Mohammed Mahmmoud Fadelallah and Pandya, Krutarth and Alraies, M Chadi},
title = {From Mechanism to Management: The Link Between Inflammatory Bowel Disease and Cardiovascular Disease},
journal = {Immunity, Inflammation and Disease},
year = {2026},
volume = {14},
number = {11},
doi = {10.1002/iid3.70570}
}
EUVIMED